Abstract:Inflammatory skin diseases include a series of disorders characterized by a strong activation of the innate and adaptive immune system in which proinflammatory cytokines play a fundamental role in supporting inflammation. Skin inflammation is a complex process influenced by various factors, including genetic and environmental factors, characterized by the dysfunction of both immune and non-immune cells. Psoriasis (PS) and atopic dermatitis (AD) are the most common chronic inflammatory conditions of the skin whose pathogeneses are very complex and multifactorial. Both diseases are characterized by an immunological dysfunction involving a predominance of Th1 and Th17 cells in PS and of Th2 cells in AD. Suppressor of cytokine signaling (SOCS) proteins are intracellular proteins that control inflammatory responses by regulating various signaling pathways activated by proinflammatory cytokines. SOCS signaling is involved in the regulation and progression of inflammatory responses in skin-resident and non-resident immune cells, and recent data suggest that these negative modulators are dysregulated in inflammatory skin diseases such as PS and AD. This review focuses on the current understanding about the role of SOCS proteins in modulating the activity of inflammatory mediators implicated in the pathogenesis of inflammatory skin diseases such as PS and AD.

What problem does this paper attempt to address?

The paper attempts to address the role and importance of Suppressor of Cytokine Signaling (SOCS) proteins in inflammatory skin diseases such as psoriasis and atopic dermatitis in regulating inflammatory mediators. ### Problems the Paper Attempts to Address: 1. **Role of SOCS Proteins in Inflammatory Skin Diseases**: The paper primarily explores the mechanisms of SOCS proteins in common inflammatory skin diseases like psoriasis (PS) and atopic dermatitis (AD). 2. **Regulation of Inflammatory Response**: As negative feedback regulators, SOCS proteins play a crucial role in modulating cytokine signaling pathways, especially the JAK/STAT pathway. By inhibiting excessive immune responses, SOCS proteins help maintain the homeostasis of the immune system. 3. **Potential Therapeutic Targets**: The study of the functions of SOCS protein family members aims to discover new therapeutic targets for treating these inflammatory skin diseases. ### Summary of Specific Content: - **Research Background**: Inflammatory skin diseases (such as PS and AD) are caused by the intense activation of the innate and adaptive immune systems. These diseases are associated with various factors, including genetic and environmental factors, leading to dysfunctions in immune and non-immune cells. - **Role of SOCS Proteins**: SOCS proteins are a class of intracellular proteins that regulate inflammatory responses by modulating various signaling pathways activated by pro-inflammatory cytokines. These proteins play a significant role in regulating inflammatory responses in both resident and non-resident immune cells in the skin. - **Specific Mechanisms**: SOCS proteins regulate cytokine signaling by inhibiting the JAK/STAT pathway, thereby affecting the differentiation and proliferation of lymphocytes such as Th1, Th2, and Th17. The functions of SOCS1 and SOCS3 proteins, in particular, have been extensively studied in this regard. - **Clinical Significance**: Understanding the mechanisms of SOCS proteins in these diseases can aid in developing new therapeutic methods, thereby better controlling the progression of inflammatory skin diseases. ### Conclusion: This paper reviews the roles of SOCS proteins in psoriasis and atopic dermatitis and emphasizes their importance as negative feedback regulators. By modulating the functions of SOCS protein family members, new ideas and methods for treating these inflammatory skin diseases can be provided.

Inflammatory Skin Diseases: Focus on the Role of Suppressors of Cytokine Signaling (SOCS) Proteins

SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation

SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer

SOCS Signaling in Autoimmune Diseases: Molecular Mechanisms and Therapeutic Implications.

Aberrant expression of suppressor of cytokine signaling (SOCS) molecules contributes to the development of allergic diseases

The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7

Unravelling the druggability and immunological roles of the SOCS-family proteins

The Role of Suppressor of Cytokine Signaling 3 in Inflammatory Bowel Disease and Its Associated Colorectal Cancer

Negative regulation of cytokine signaling by CIS/SOCS family proteins and their roles in inflammatory diseases

Skin immunity and its dysregulation in psoriasis.

OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augmenting IFN-1‒Induced Jak1‒Signal Transducer and Activator of Transcription 1 Phosphorylation in Psoriasis.

Suppressor of Cytokine Signaling-1 Has IFN-γ-Independent Actions in T Cell Homeostasis1

Suppressor of Cytokine Signaling-1 Has IFN-γ-Independent Actions in T Cell Homeostasis

SOCS modulates JAK-STAT pathway as a novel target to mediate the occurrence of neuroinflammation: Molecular details and treatment options

Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease

Skin Immunity and Its Dysregulation in Psoriasis

Suppressor of cytokine signaling-1 has IFN-gamma-independent actions in T cell homeostasis.

[SOCS3: a Potential Therapeutic Target for Many Human Diseases].

Immunopathology and Immunotherapy of Inflammatory Skin Diseases

Suppressor of Cytokine Signaling-1 and Lung Diseases

Suppressors of cytokine signalling and periodontal diseases